Clinical effect of Bailing capsule on patients after renal transplantation
10.12206/j.issn.2097-2024.202206127
- VernacularTitle:百令胶囊用于肾移植术后患者的临床疗效分析
- Author:
Suqiu PANG
1
Author Information
1. No. 910 Hospital of Joint Logistics Support Force, Quanzhou 362000, China.
- Keywords:
Bailing capsule;
tacrolimus;
cyclosporine A;
renal transplantation;
immunoregulation
- From:
Journal of Pharmaceutical Practice and Service
2024;42(2):82-85
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of Bailing capsule on renal function and other organ systems in 60 patients after renal transplantation in No. 910 Hospital of Joint Logistics Support Force. Methods 60 patients with renal allograft in 2018−2020 were divided into 2 groups according to different immunosuppressive regimens. In the control group, 35 cases were treated with MMF + CsA or FK506; in the treatment group, 25 cases were treated with MMF + CsA or FK506 + Bailing capsule. Blood and urine routine, liver and renal function and uric acid were measured after operation. The dosage of immunosuppressive drugs was recorded in stages at 48 weeks. Results The urinary red and white blood cell counts, blood aspartate transaminase and alanine transaminase, serum uric acid, total bilirubin and direct bilirubin in the treatment group were significantly less than those in the control group, while the serum total protein and albumin were significantly higher than those in the control group. The number of red blood cells and white blood cells in the treatment group was significantly higher than that in the control group at 12-48 weeks after kidney transplantation, and that in the lymphocyte group was significantly higher than that in the control group at 24-48 weeks after kidney transplantation. The dosage of CsA and FK506 in the treatment group was significantly lower than that in the control group after 48 weeks. Conclusion Bailing capsule could protect liver and kidney, stimulate hematopoiesis, improve hypoalbuminemia and reduce the dosage of immunosuppressant, which could be an ideal immunomodulator.
